Mitochondria-derived peptide MOTS-c alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice by activating Nrf2 pathway.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type: Original study
Study category (metadata hint): Animal
Published: 2026-03-07
Authors: Chen D, Zhou MH, Zhu WY, Xing ZX, Li SP, Wu YX, Sun XL, Sun P
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: National Natural Science Foundation of China; Fundamental Research Funds for the Central Universities; Wuxi Health and Family Planning Commission; Shandong Province Natural Science Foundation
Identifiers: DOI: 10.1016/j.ejphar.2026.178726 · PMID: 41802484
First found: Sep 25, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗